Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited has reported a change in the interest of director Liz Dallimore, where she exercised 1,590,909 options and consequently increased her holding in ordinary shares to 1,640,909, while also canceling 909,091 options using a cashless exercise mechanism based on the volume-weighted average price. This change in director’s interest is part of the company’s ongoing adherence to ASX listing rules and corporate governance requirements.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
